Cargando…

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics

The high mobility group box 1 gene (HMGB1) plays a prominent role in cancer progression, angiogenesis, invasion, and metastasis. This study explored the effect of HMGB1 polymorphisms on clinicopathological characteristics of urothelial cell carcinoma (UCC). In total, 1293 participants (431 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Sheng-Chun, Wang, Shian-Shiang, Li, Jian-Ri, Chen, Chuan-Shu, Yang, Chun-Kuang, Chiu, Kun-Yuan, Cheng, Chen-Li, Ou, Yen-Chuan, Ho, Hao-Chung, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299401/ https://www.ncbi.nlm.nih.gov/pubmed/30588197 http://dx.doi.org/10.7150/ijms.27901

Ejemplares similares

Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Wang, Shian-Shiang, et al.
Publicado: (2013)

Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics
por: Lin, Chia-Yen, et al.
Publicado: (2019)

The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan
por: Chang, Li-Wen, et al.
Publicado: (2023)

Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
por: Hu, Ju-Chuan, et al.
Publicado: (2020)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
por: Tsay, Ming-Dow, et al.
Publicado: (2019)

Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features
por: Yu, Yung-Luen, et al.
Publicado: (2014)

Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy
por: Chang, Li-Wen, et al.
Publicado: (2023)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
por: Chen, Chuan-Shu, et al.
Publicado: (2020)

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
por: Hu, Ju-Chuan, et al.
Publicado: (2021)

Real world treatment sequences and outcomes for metastatic renal cell carcinoma
por: Lai, Gu-Shun, et al.
Publicado: (2023)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy
por: Hsieh, Hsiang-Chen, et al.
Publicado: (2022)

The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
por: Chou, Ying-Erh, et al.
Publicado: (2020)

Impacts of AURKA Genetic Polymorphism on Urothelial Cell Carcinoma Development
por: Huang, Chia-Hung, et al.
Publicado: (2019)

Impact of Long Non-Coding RNA HOTAIR Genetic Variants on the Susceptibility and Clinicopathologic Characteristics of Patients with Urothelial Cell Carcinoma
por: Tung, Min-Che, et al.
Publicado: (2019)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma
por: Weng, Wei-Chun, et al.
Publicado: (2023)

Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Weng, Wei-Chun, et al.
Publicado: (2020)

Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
por: Chang, Li-Wen, et al.
Publicado: (2021)

Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma
por: Lin, Yung-Wei, et al.
Publicado: (2017)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
por: Yang, Cheng-Kuang, et al.
Publicado: (2023)

Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population
por: Tung, Min-Che, et al.
Publicado: (2018)

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience
por: Yang, Chen-Kuang, et al.
Publicado: (2014)

Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development
por: Yang, Po-Jen, et al.
Publicado: (2019)

Associations of VEGF-C Genetic Polymorphisms with Urothelial Cell Carcinoma Susceptibility Differ between Smokers and Non-Smokers in Taiwan
por: Tung, Min-Che, et al.
Publicado: (2014)

Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study
por: Li, Jian-Ri, et al.
Publicado: (2022)

First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2022)

Robot-Assisted Laparoscopic Nephroureterectomy versus Hand-Assisted Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: A Matched Comparison Study
por: Hu, Che-Yuan, et al.
Publicado: (2015)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017)

Intraoperative calculus or hemorrhage in transurethral seminal vesiculoscopy as a risk factor for recurrent hemospermia
por: Mei, Cheng-En, et al.
Publicado: (2022)

Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study
por: Chen, Wei-Cheng, et al.
Publicado: (2023)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Susceptibility to Environmental Factors and the Clinicopathologic Development of Oral Cancer
por: Lin, Chiao-Wen, et al.
Publicado: (2012)

Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects
por: Hu, Weiwei, et al.
Publicado: (2017)

Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Chien, Ming-Hsien, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e141jijulrpktncrfqlo11si33